← Back to headlines
Amneal Pharmaceuticals Receives 'Buy' Rating from UBS
Amneal Pharmaceuticals has been rated 'Buy' in new research coverage by UBS, citing an expanding growth pipeline for the company.
19 Apr, 19:01 — 19 Apr, 19:01
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Farmers' Group Criticizes Proposed Pax Silica Economic Zone in Philippines
just now
Philippine President Marcos Orders P17.27 Billion for Classroom Construction
just now
Philippine President Marcos Pushes P46.22 Billion for Infrastructure Projects
just now